RNS Number : 3872U
SigmaRoc PLC
22 November 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

THIS ANNOUNCEMENT IS NOT AN ADMISSION DOCUMENT OR A PROSPECTUS AND DOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL OR ISSUE OR A SOLICITATION OF AN OFFER TO SUBSCRIBE FOR OR BUY ANY SECURITIES WHERE SUCH OFFER WOULD BREACH ANY APPLICABLE LAW OR REGULATION. INVESTORS SHOULD NOT PURCHASE OR SUBSCRIBE FOR ANY TRANSFERRABLE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT NOR SHOULD THEY RELY ON THIS ANNOUNCEMENT IN CONNECTION WITH ANY CONTRACT OR COMMITMENT WHATSOEVER EXCEPT IN COMPLIANCE WITH APPLICABLE SECURITIES LAWS ON THE BASIS OF THE INFORMATION IN THE ADMISSION DOCUMENT TO BE PUBLISHED BY THE COMPANY IN CONNECTION WITH THE PLACING OF ORDINARY SHARES BY THE COMPANY AND THE PROPOSED ADMISSION OF ITS ISSUED AND TO BE ISSUED ORDINARY SHARES TO TRADING ON AIM, A MARKET OPERATED BY LONDON STOCK EXCHANGE PLC. BEFORE ANY PURCHASE OR SUBSCRIPTION OF SHARES, PERSONS VIEWING THIS ANNOUNCEMENT SHOULD ENSURE THAT THEY FULLY UNDERSTAND AND ACCEPT THE RISKS WHICH ARE SET OUT IN THE ADMISSION DOCUMENT WHEN PUBLISHED.

COPIES OF THE ADMISSION DOCUMENT WILL, FOLLOWING PUBLICATION, BE AVAILABLE DURING NORMAL BUSINESS HOURS ON ANY DAY (EXCEPT SATURDAYS, SUNDAYS AND PUBLIC HOLIDAYS) FROM THE REGISTERED OFFICE OF THE COMPANY AND ON THE COMPANY'S WEBSITE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.

 

22 November 2023

 

SIGMAROC PLC

 

("SigmaRoc", the "Company" and, together with its subsidiaries, the "Existing Group")

 

Acquisition of the Deal 1 Targets from CRH

Successful Placing of 418,464,565 new Ordinary Shares at 47.5 pence per share

REX Intermediaries Offer of 2,588,066 new Ordinary Shares at 47.5 pence per share

Reverse Takeover

and

Notice of General Meeting

 

SigmaRoc, the AIM quoted lime and limestone group, is pleased to announce that, further to its earlier announcement of 22 November 2023 (the "Placing Announcement"), it has conditionally raised c. £200 million (before expenses) via the conditional issue of 418,464,565 new ordinary shares of £0.01 each in the capital of the Company ("Ordinary Shares") at a price of 47.5 pence per share (the "Placing Price") (the "Placing").  

 

The Company is also pleased to announce that the REX Intermediaries Offer which was also announced earlier, has conditionally raised gross proceeds of approximately £1.3 million, via the subscription for, in aggregate, 2,588,066 new Ordinary Shares at the Placing Price (the Placing and the REX Intermediaries Offer being the "Fundraising").

 

As set out in the Placing Announcement, the net proceeds of the Fundraising will be used to part satisfy the cash consideration due on Deal 1 Completion.

 

Due to its size, the acquisition of the Deal 1 Targets comprises a reverse takeover of the Company pursuant to Rule 14 of the AIM Rules for Companies and completion of the Deal 1 Acquisition is therefore conditional on, inter alia, the approval of Shareholders at the General Meeting.

 

In accordance with Rule 14 of the AIM Rules for Companies, the Company's Ordinary Shares have been suspended from trading on AIM with effect from 7:30 a.m. today. The Company's Ordinary Shares will remain suspended until such time as either an admission document is published, (which is expected to be on Thursday 23 November 2023), or an announcement is released confirming that the Acquisitions are not proceeding.

 

The Placing is conditional upon, amongst other things, Admission becoming effective, the Master Acquisition Agreement becoming unconditional, and the Placing Agreement not being terminated in accordance with its terms.

 

The Placing Shares will be credited as fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares, including the right to receive all dividends and other distributions (if any) declared, made or paid on or in respect of the Ordinary Shares after the date of issue of the Placing Shares to the relevant Placees.

 

The Board currently expects Admission to occur on 4 January, 2024. A further announcement will be made in due course, as and when appropriate.

 

The General Meeting to approve the acquisition of the Deal 1 Targets and the issue of the Fundraising Shares will be held at 11 a.m. on 11 December 2023 at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London, EC4R 3TT.

 

Defined terms used throughout this announcement have the meanings set out in the Placing Announcement unless the context requires otherwise. 

 

Max Vermorken, CEO of SigmaRoc, commented on the transaction:

 

"I am delighted to see many of our existing shareholders continuing to offer their support for SigmaRoc and our buy-and-build strategy. We are encouraged by the quality of our new shareholders which we are pleased to see provides confidence in our plans for the future. This acquisition of lime operations from CRH plc enables SigmaRoc to expand its footprint in the European lime market significantly and it also creates further opportunities that we look forward to exploring."

DIRECTORS AND SENIOR MANAGERS' PARTICIPATION IN THE PLACING

Directors have subscribed for, in aggregate, 831,582 Placing Shares as set out below:

Name

Existing Shareholding

Percentage of Existing Ordinary Shares

Number of Placing Shares subscribed for in the Placing

Resultant shareholding on Admission

Percentage of Enlarged Share Capital

David Barrett

 3,434,180

0.5%

421,054

 3,855,234

0.3%

Max Vermorken

 827,034

0.1%

210,527

 1,037,561

0.1%

Garth Palmer

 671,776

0.1%

157,895

 829,666

0.1%

Tim Hall

 400,176

0.1%

42,106

 442,282

0.0%

 

In addition, senior management have subscribed for, in aggregate, 1,303,949 Placing Shares.  

 

As part of the placing, a CRH Group company has conditionally subscribed for 171,578,948 Placing Shares. CRH's expected holding on Admission of the Placing Shares as a percentage of the Enlarged Share Capital is 15.4 per cent. It will reapply an equivalent amount of the consideration paid to the Sellers under the Master Purchase Agreement to subscribe for such shares.

ADMISSION, SETTLEMENT AND DEALINGS

Application will be made to the London Stock Exchange for Admission of the Placing Shares to be issued pursuant to the Placing and the re-admission of the Enlarged Share Capital to trading on AIM.

The Placing and the Deal 1 Acquisition are inter-conditional and are both subject to, inter alia, Shareholder approval at the General Meeting. Should these conditions not be satisfied, Admission will not occur.

The Company currently expects to complete the Deal 1 Acquisition (and therefore for Admission to occur) on 4 January 2024. 

The Placing Shares will not be admitted to trading on any stock exchange other than AIM.

DIRECTORS' RECOMMENDATION AND VOTING INTENTION

The Directors consider that the Proposals are in the best interests of the Shareholders and the Company as a whole and, accordingly, they recommend that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting, as they have irrevocably undertaken to do in respect of their own beneficial holdings of 5,333,166 Ordinary Shares, representing approximately 0.77 per cent. of the Company's Existing Ordinary Share capital.

 

Information on SigmaRoc is available on the Company's website at: www.sigmaroc.com.

For further information, please contact:

SigmaRoc plc

Max Vermorken (Chief Executive Officer)

Garth Palmer (Chief Financial Officer)

Tom Jenkins (Head of Investor Relations)

 

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com 

Liberum Capital Limited (Nominated and Financial Adviser, Joint Bookrunner and Co-Broker)

Dru Danford / Ben Cryer / Mark Harrison / John More / Anake Singh

Tel: +44 (0) 203 100 2000

 

Peel Hunt (Joint Bookrunner and Co-Broker)

Investment Banking

Mike Bell / Ed Allsopp / Ben Harrington

ECM Syndicate & Broking

Sohail Akbar / Jock Maxwell Macdonald / Tom Ballard

 

Tel: +44 (0) 20 7418 8900

Rothschild & Co acting through Redburn Atlantic (Joint Bookrunner and Financial Adviser)

Adam Young / Ben Glaeser

             Tel: +44 (0) 20 7000 2020



BNP Paribas (Joint Bookrunner and Financial Adviser)

Tel: +44 (0) 20 7595 9523

Tom Snowball / Matt Randall / Lauren Davies / Deepak Sran


 

Santander Group (Joint Bookrunner and Financial Adviser)

Javier Mata / Oliver Tucker

 

 

Tel: +34 912572388

Walbrook PR Ltd (Public Relations)


Tom Cooper / Nick Rome

Tel: +44 20 7933 8780 / sigmaroc@walbrookpr.com

Mob: +44 7971 221972

 

About SigmaRoc plc

SigmaRoc is an AIM-quoted lime and limestone group targeting quarried materials assets in the UK and Northern Europe. It seeks to create value by purchasing assets in fragmented materials markets and extracting efficiencies through active management and by forming the assets into larger groups. It seeks to de-risk its investments via strong asset backing at its projects through the selection of projects with strong asset-backing.

Pre-Emption Group Reporting

 

The Fundraising is a non-pre-emptive issue of equity securities for cash and accordingly the Company makes the following post transaction report in accordance with the most recently published Pre-Emption Group Statement of Principles (2022).

 

Name of Issuer

SigmaRoc plc

Transaction details

In aggregate, the Fundraising of 421,052,631 new Ordinary Shares (comprising 418,464,565 Placing Shares and 2,588,066 REX Intermediaries Offer Shares) represents approximately 60.7% of the Company's issued ordinary share capital. Settlement for the new Ordinary Shares and Admission is expected to take place on 4 January 2024.

Use of proceeds

The net proceeds of the Fundraising will be used to fund part of the consideration payable for the acquisition of the European Lime assets from CRH Plc.

Quantum of proceeds

In aggregate, the Fundraising will raise gross proceeds of approximately £200 million with estimated net proceeds (after the deduction expenses incurred in connection with the Fundraising) receivable by the Company of approximately £193.2million.

The subscription by a member of the CRH Group for 171,578,948 Placing Shares will be satisfied by it reapplying an equivalent amount of the consideration paid to the Sellers under the Master Purchase Agreement to subscribe for such shares.

Discount

The Placing Price of 47.5 pence represents a discount of approximately 5.4 per cent. to the closing share price of 50.2 pence on 21 November 2023.

Allocations

Soft pre-emption has been adhered to in the allocations process. Management was involved in the allocations process, which has been carried out in compliance with the MiFID II Allocation requirements. Allocations made outside of soft pre-emption were preferentially directed towards existing shareholders in excess of their pro rata entitlement, or towards new shareholders with a long only investment strategy and wall-crossed accounts

Consultation

Liberum, Peel Hunt, Redburn, BNP Paribas and Santander conducted a pre-launch wall-crossing exercise in accordance with the market-sounding regime under the Market Abuse Regulation, including consulting with major shareholders, to the extent reasonably practicable and permitted by law.

Retail investors

The Company values its retail investor base and has therefore provided its existing shareholders who cannot participate in the Placing with the opportunity to participate on the same terms as other subscribers in the Placing, via the REX Intermediaries Offer (the "REX Intermediaries Offer").

The Fundraising included an offer for a maximum of 10,526,315 REX Intermediaries Offer Shares, via the REX Intermediaries Offer. Retail shareholders, who participated in the REX Intermediaries Offer, were able to do so at the same Placing Price offered to all of the other investors participating in the Placing.

The REX Intermediaries Offer was only available to existing shareholders.

 

IMPORTANT INFORMATION

 

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or "US")), Canada, Australia, New Zealand, the Republic of South Africa, Japan, any member state of the EEA or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction.

 

The Ordinary Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "US Securities Act"), or under the applicable securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, taken up, resold, transferred or delivered, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from the registration requirements of the US Securities Act and in compliance with the securities laws of any relevant state or other jurisdiction of the United States. There will be no public offering of the Ordinary Shares in the United States. The Ordinary Shares have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of any offering of the Ordinary Shares, or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in this announcement, will not be accepted.

 

This announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy or subscribe for, securities in the United States, Canada, Australia, New Zealand, the Republic of South Africa, Japan, or in any jurisdiction in which such offer or solicitation is unlawful. This announcement is not for publication or distribution, directly or indirectly, in whole or in part, in or into the United States, Canada, Australia, New Zealand, the Republic of South Africa or Japan, nor in any country or territory where to do so may contravene local securities laws or regulations. The distribution of this announcement (or any part of it or any information contained within it) in other jurisdictions may be restricted by law and therefore persons into whose possession this announcement (or any part of it or any information contained within it) comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities law of any such jurisdictions. The Ordinary Shares have not been and will not be registered under the US Securities Act nor under the applicable securities laws of any state or other jurisdiction of the United States or any province or territory of Canada, Australia, New Zealand, the Republic of South Africa or Japan. Accordingly, the Ordinary Shares may not be offered or sold directly or indirectly in or into the United States, Canada, Australia, New Zealand, the Republic of South Africa or Japan or to any resident of the United States, Canada, Australia, New Zealand, the Republic of South Africa or Japan except pursuant to an exemption to applicable registration requirements.

 

The distribution of this announcement and other information in connection with the Placing and Admission in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Neither this announcement nor any part of it nor the fact of its distribution shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

 

Liberum Capital Limited, which is authorised and regulated by the FCA in the United Kingdom, is acting as Nominated Adviser, Financial Adviser and Joint Bookrunner to the Company. Liberum Capital Limited, as Nominated Adviser, has not authorised the contents of, or any part of, this announcement, and no liability whatsoever is accepted by Liberum Capital Limited for the accuracy of any information or opinions contained in this announcement or for the omission of any material information. The responsibilities of Liberum Capital Limited as the Company's Nominated Adviser under the AIM Rules for Companies and the AIM Rules for Nominated Advisers are owed solely to London Stock Exchange plc and are not owed to the Company or to any director or shareholder of the Company or any other person, in respect of its decision to acquire shares in the capital of the Company in reliance on any part of this announcement, or otherwise. Liberum Capital Limited will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

Peel Hunt LLP is authorised and regulated by the FCA in the United Kingdom and is acting as Joint Bookrunner exclusively for the Company and no one else in connection with the Placing, and Peel Hunt LLP will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

Redburn (Europe) Limited is authorised and regulated by the FCA in the United Kingdom and is acting exclusively as Joint Bookrunner for the Company and no one else in connection with the Placing, and Redburn (Europe) Limited will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

BNP PARIBAS is authorised and regulated by the FCA in the United Kingdom and is acting exclusively as Joint Bookrunner for the Company and no one else in connection with the Placing, and BNP Paribas will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

Banco Santander S.A. is registered with the Bank of Spain (Banco de España) under registration number 0049 with CIF A-39000013. Banco Santander S.A., London Branch is authorised by the Bank of Spain and subject to limited regulation by the FCA and PRA and is acting as Joint Bookrunner exclusively for the Company and no one else in connection with the Placing, and Santander will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Garth Palmer.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014, as it forms part of UK law by virtue of the European Union Withdrawal Act 2018 ("UK MAR"), encompassing information relating to the Proposals described above, and is disclosed in accordance with the Company's obligations under Article 17 of UK MAR. In addition, market soundings (as defined in UK MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in UK MAR), as permitted by UK MAR.  This inside information is set out in this announcement. Therefore, upon publication of this announcement, those persons that received such inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

 

This announcement does not constitute a recommendation concerning any investor's option with respect to the Placing. Each investor or prospective investor should conduct his, her or its own investigation, analysis and evaluation of the business and data described in this announcement and publicly available information. The price and value of securities can go down as well as up. Past performance is not a guide to future performance.  

 

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Nominated Adviser or Joint Bookrunners or by any of their respective affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will", or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the directors' current intentions, beliefs or expectations concerning, among other things, the Company's results of operations, financial condition, liquidity, prospects, growth, strategies and the Company's markets. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Actual results and developments could differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements in this announcement are based on certain factors and assumptions, including the directors' current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. Whilst the directors consider these assumptions to be reasonable based upon information currently available, they may prove to be incorrect. Save as required by applicable law or regulation, the Company undertakes no obligation to release publicly the results of any revisions to any forward-looking statements in this announcement that may occur due to any change in the directors' expectations or to reflect events or circumstances after the date of this announcement.

 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQPPGPPGUPWGRP